Works matching IS 03407004 AND DT 2015 AND VI 64 AND IP 3
Results: 12
Expression and function of Toll-like receptors in peripheral blood mononuclear cells from patients with ovarian cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 3, p. 275, doi. 10.1007/s00262-014-1632-x
- By:
- Publication type:
- Article
Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 3, p. 287, doi. 10.1007/s00262-014-1633-9
- By:
- Publication type:
- Article
Blockade of CTLA-4 promotes the development of effector CD8 T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 3, p. 311, doi. 10.1007/s00262-014-1634-8
- By:
- Publication type:
- Article
Protection from tumor recurrence following adoptive immunotherapy varies with host conditioning regimen despite initial regression of autochthonous murine brain tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 3, p. 325, doi. 10.1007/s00262-014-1635-7
- By:
- Publication type:
- Article
Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 3, p. 337, doi. 10.1007/s00262-014-1636-6
- By:
- Publication type:
- Article
Fever and the use of paracetamol during IL-2-based immunotherapy in metastatic melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 3, p. 349, doi. 10.1007/s00262-014-1637-5
- By:
- Publication type:
- Article
Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 3, p. 357, doi. 10.1007/s00262-014-1638-4
- By:
- Publication type:
- Article
A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN).
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 3, p. 367, doi. 10.1007/s00262-014-1640-x
- By:
- Publication type:
- Article
Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 3, p. 381, doi. 10.1007/s00262-014-1642-8
- By:
- Publication type:
- Article
Tumor-induced CD14HLA-DR myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 3, p. 389, doi. 10.1007/s00262-014-1646-4
- By:
- Publication type:
- Article
Immunotherapies and novel combinations: the focus of advances in the treatment of melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 3, p. 271, doi. 10.1007/s00262-014-1647-3
- By:
- Publication type:
- Article
Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigm.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 3, p. 299, doi. 10.1007/s00262-014-1622-z
- By:
- Publication type:
- Article